Hydrogenology
Hydrogenology editorial study record

Hydrogen inhalation ameliorates lung inflammation in mice with asthma

Li H et al. · Eur J Med Res. 2025;30:1024.

PreclinicalOther formsPublished 2025
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Randomized mouse ovalbumin-asthma experiment

Research topic

Respiratory health

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Female C57BL/6 mice sensitized and challenged with ovalbumin

Sample

32 mice; the article describes groups of eight

Duration

One hour daily for 7 consecutive days

Intervention

Whole-body exposure to 15% H₂ in air for 1 hour daily over 7 consecutive days

Hydrogen form

H₂ diluted in air — not Brown’s gas.

H₂ specification

15% H₂ in air at a reported total chamber flow of 4 L/min.

H₂ flow

600 mL/min H₂ — calculated from 15% H₂ in the reported 4 L/min total mixture.

O₂ delivered with H₂

No separate O₂ stream or O₂ flow is reported; the balance is described as air.

Comparator

Ovalbumin-asthma mice exposed to ambient atmosphere, plus non-asthmatic controls

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Airway responsiveness, type-2 cytokines, IgE, regulatory cytokines, lung histology, MDA and SOD

Reported result

The article reports lower airway responsiveness, inflammation, IgE and MDA and higher SOD and regulatory-cytokine expression with H₂.

Results-extraction completeness

Allocation, concentration, total flow, timing, outcomes, funding and conflicts checked in the open-access full text.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small preclinical asthma model. The 600 mL/min figure is a calculated H₂ component of chamber flow, not a separately measured animal inspired-flow value.

Applies directly to

Ovalbumin-induced airway inflammation in mice, not clinical asthma.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 41146240 · DOI: 10.1186/s40001-025-03296-7

Publisher access

Open-access full text is available through PMC and the publisher.

Extraction basis

Open-access publisher/PMC full text and PubMed record; no retraction or expression of concern was shown in the checked records on 7 August 2026.

Record revision

2026-08-10